Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Situnayake

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
British Journal of Rheumatology|January 1, 1988
Can 'disease modifying' drugs influence outcome in rheumatoid arthritis?R D Situnayake
Annals of the Rheumatic Diseases|June 1, 1997
Dyslipidemia and rheumatoid arthritisR D Situnayake, G Kitas
Annals of the Rheumatic Diseases|November 1, 1992
Sulphasalazine induced hepatitis in adult Still's diseaseJ Crowley, R D Situnayake
The Journal of Rheumatology|October 1, 1990
Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment responseR D Situnayake, B McConkey
The Journal of Rheumatology|January 1, 1988
Effects of rifampicin with and without isoniazid in rheumatoid arthritisB McConkey, R D Situnayake
British Journal of Rheumatology|May 1, 1985
Resin-coated 5-aminosalicylic acid (Asacol) in rheumatoid arthritisR D Situnayake, B McConkey
Drugs|January 1, 1986
Long term outcome of treatment with sulphasalazine in rheumatoid arthritisR D Situnayake, B McConkey
The Journal of Rheumatology|May 1, 1991
Rifampicin in rheumatoid arthritisB McConkey, R D Situnayake
British Medical Journal (Clinical Research Ed.)|July 13, 1985
Which component of sulphasalazine is active in rheumatoid arthritis?R D Situnayake, B McConkey
Respiratory Medicine|May 1, 1991
Recurrent pneumothorax and malignant pleural mesotheliomaR D Situnayake, W G Middleton
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Rheumatology|January 1, 1988
Can 'disease modifying' drugs influence outcome in rheumatoid arthritis?R D Situnayake
Annals of the Rheumatic Diseases|June 1, 1997
Dyslipidemia and rheumatoid arthritisR D Situnayake, G Kitas
Annals of the Rheumatic Diseases|November 1, 1992
Sulphasalazine induced hepatitis in adult Still's diseaseJ Crowley, R D Situnayake
The Journal of Rheumatology|October 1, 1990
Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment responseR D Situnayake, B McConkey
The Journal of Rheumatology|January 1, 1988
Effects of rifampicin with and without isoniazid in rheumatoid arthritisB McConkey, R D Situnayake
British Journal of Rheumatology|May 1, 1985
Resin-coated 5-aminosalicylic acid (Asacol) in rheumatoid arthritisR D Situnayake, B McConkey
Drugs|January 1, 1986
Long term outcome of treatment with sulphasalazine in rheumatoid arthritisR D Situnayake, B McConkey
The Journal of Rheumatology|May 1, 1991
Rifampicin in rheumatoid arthritisB McConkey, R D Situnayake
British Medical Journal (Clinical Research Ed.)|July 13, 1985
Which component of sulphasalazine is active in rheumatoid arthritis?R D Situnayake, B McConkey
Respiratory Medicine|May 1, 1991
Recurrent pneumothorax and malignant pleural mesotheliomaR D Situnayake, W G Middleton
Pageof 4